We support the clinical study of rare disease diagnosis by genetic testing. Ask a research collaboration if you are a physician and in need of a diagnosis of rare patients.
Patients undiagnosed from the previous genetic testing have a chance to get diagnosed from reanalyses on newly discovered genetic diseases and updated evidences. 3billion helps you diagnose those patients by reanalyses.
We improve the genome analysis technology including variant calling, annotation, interpretation, etc.
We aim to develop AI technologies to revolutionize the rare disease drug discovery, especially on novel target discovery, drug candidate generation, and safety estimation at Phase I level.